Since the suspected link of LRH‐1 and GLS2‐induced glutaminolysis, we tested whether manipulation of the LRH‐1 signalling pathway by DLPC (a widely reported LRH‐1 agonist) could prevent the progression of DKD.19 The gene discussed is GLS2; the disease is diabetic kidney disease.